Actively Recruiting

Phase 1
Age: 18Years - 65Years
All Genders
Healthy Volunteers
NCT06670950

A Phase 1 Single Dose and Multiple Ascending Dose Study to Assess the Relative Bioavailability, Food Effect, Safety, Tolerability and Pharmacokinetics of SYT-510 in Healthy Participants

Led by Synendos Therapeutics AG · Updated on 2024-11-01

90

Participants Needed

1

Research Sites

30 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Part 1 aims to investigate the relative bioavailability of a new formulation and to assess potential food effects following oral administration of SYT-510. Part 1 will then guide dosing in Part 2, a multiple dose study which aims to assess safety, tolerability and pharmacokinetic of multiple SYT-510 administrations.

CONDITIONS

Official Title

A Phase 1 Single Dose and Multiple Ascending Dose Study to Assess the Relative Bioavailability, Food Effect, Safety, Tolerability and Pharmacokinetics of SYT-510 in Healthy Participants

Who Can Participate

Age: 18Years - 65Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Males or females of non-childbearing potential aged 18 to 65 years at informed consent
  • Normal ECG with no clinically relevant deviations
  • Body mass index between 18 and 30 kg/m2 and minimum weight of 50 kg
Not Eligible

You will not qualify if you...

  • Current or recurrent diseases that may interfere with study conduct
  • Laboratory test results outside normal range
  • Positive tests for alcohol or drugs of abuse
  • Use of investigational drug within 90 days before study drug
  • Known or suspected intolerance or hypersensitivity to SYT-510 or related compounds
  • History of severe allergic reactions such as anaphylaxis or angioedema
  • Current smokers or those who smoked within the last 6 months

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Richmond Pharmacology Ltd

London, United Kingdom

Actively Recruiting

Loading map...

Research Team

S

Synendos Therapeutics AG

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here